SCHEMBL21119234

SCHEMBL21119234

C=CC(=O)NC(=O)C(C=C)(CC)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ TGM2 P21980 2/20 0.40
▸ TSHR P16473 1/20 0.37
▸ HTT P42858 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ HDAC1 Q13547 2/20 0.36
▸ HDAC3 O15379 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC10 Q969S8 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ HDAC9 Q9UKV0 1/20 0.36
▸ HDAC5 Q9UQL6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21119238 0.83 ALDH1A1 (0.40) ALDH1A1CYP2C19CYP3A4CYP2C9TSHR
SCHEMBL11327202 0.79 ALDH1A1 (0.49) ALDH1A1CYP2C19CYP3A4CYP2C9TSHR
SCHEMBL20556841 0.79 ALDH1A1 (0.49) ALDH1A1CYP2C19CYP3A4CYP2C9TSHR
SCHEMBL21119239 0.76 HTT (0.51) ALDH1A1CYP2C19TSHRHTTLMNA
SCHEMBL7868749 0.72 ALDH1A1 (0.54) ALDH1A1CYP2C19CYP3A4CYP2C9TGM2
SCHEMBL730210 0.69 ALDH1A1 (0.53) ALDH1A1CYP2C19CYP3A4CYP2C9TGM2
SCHEMBL10483557 0.68 ALDH1A1 (0.47) ALDH1A1CYP2C19TSHRHTTLMNA
SCHEMBL20556964 0.68 ALDH1A1 (0.47) ALDH1A1CYP2C19TSHRHTTLMNA
SCHEMBL7262260 0.67 ALDH1A1 (0.42) ALDH1A1CYP2C19CYP2C9TSHRHTT
Malonic Acid SCHEMBL30721050 0.67 ALDH1A1 (0.42) ALDH1A1CYP2C19CYP3A4CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10336678-B2 Compositions and methods for preparing β,γ-unsaturated acids CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2019-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336678-B2 Compositions and methods for preparing β,γ-unsaturated acids ELOVL5, FASN, ACSL5 ALDH1A1 239/4885CYP2C19 1453/4885CYP3A4 689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback